Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Cash & Current Investments (2023 - 2025)

Historic Cash & Current Investments for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $228.7 million.

  • Beta Bionics' Cash & Current Investments rose 120820.32% to $228.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $228.7 million, marking a year-over-year increase of 120820.32%. This contributed to the annual value of $103.6 million for FY2024, which is 705.98% up from last year.
  • According to the latest figures from Q3 2025, Beta Bionics' Cash & Current Investments is $228.7 million, which was up 120820.32% from $249.7 million recorded in Q2 2025.
  • In the past 5 years, Beta Bionics' Cash & Current Investments registered a high of $249.7 million during Q2 2025, and its lowest value of $13.0 million during Q2 2024.
  • Its 3-year average for Cash & Current Investments is $120.3 million, with a median of $100.2 million in 2023.
  • In the last 5 years, Beta Bionics' Cash & Current Investments surged by 705.98% in 2024 and then skyrocketed by 181664.75% in 2025.
  • Over the past 3 years, Beta Bionics' Cash & Current Investments (Quarter) stood at $96.7 million in 2023, then increased by 7.06% to $103.6 million in 2024, then skyrocketed by 120.79% to $228.7 million in 2025.
  • Its last three reported values are $228.7 million in Q3 2025, $249.7 million for Q2 2025, and $231.5 million during Q1 2025.